Moleculin Biotech (MBRX) Announces Proposed Underwritten Public Offering

Go back to Moleculin Biotech (MBRX) Announces Proposed Underwritten Public Offering
METABASIS THERAPEUT (NASDAQ: MBRX) Delayed: 0.60 +0.03 (5.26%)
Previous Close $0.57    52 Week High $9.58 
Open $0.55    52 Week Low $2.34 
Day High $0.67    P/E N/A 
Day Low $0.53    EPS $-0.34 
Volume 2,612,435